EligibleTrials

HIV Prevention With PrEP Among People on Opioid Replacement Therapy

Recruiting · NCT07160075 · Interventional (participants receive a specific treatment) · Lead sponsor: Cara Spence

View the official record on ClinicalTrials.gov →
HIV

Interventions studied

Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs

What this trial is about

The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest / acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.

Who can take part

Age range
16 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

6 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.